Abstract
A tic is a stereotyped repetitive involuntary movement or sound, frequently preceded by premonitory sensations or urges. Most tic disorders are genetic or idiopathic in nature, possibly due to a developmental failure of inhibitory function within frontal-subcortical circuits modulating volitional movements. Currently available oral medications can reduce the severity of tics, but rarely eliminate them. Botulinum toxin injections can be effective if there are a few particularly disabling motor tics. Deep brain stimulation has been reported to be an effective treatment for the most severe cases, but remains unproven. A comprehensive evaluation accounting for secondary causes, psychosocial factors, and comorbid neuropsychiatric conditions is essential to successful treatment of tic disorders.
MeSH terms
-
Adolescent
-
Adrenergic alpha-Agonists / therapeutic use
-
Adult
-
Antipsychotic Agents / therapeutic use
-
Attention Deficit Disorder with Hyperactivity / complications
-
Attention Deficit Disorder with Hyperactivity / drug therapy
-
Behavior Therapy
-
Botulinum Toxins, Type A / therapeutic use
-
Brain Diseases / complications
-
Child
-
Combined Modality Therapy
-
Deep Brain Stimulation
-
Diagnosis, Differential
-
Disease Management
-
Dopamine Agents / therapeutic use
-
Drug Therapy, Combination
-
Humans
-
Mental Disorders / complications
-
Obsessive-Compulsive Disorder / complications
-
Obsessive-Compulsive Disorder / drug therapy
-
Patient Education as Topic
-
Stereotypic Movement Disorder / diagnosis
-
Tics / diagnosis
-
Tics / drug therapy
-
Tics / etiology
-
Tics / physiopathology
-
Tics / therapy*
Substances
-
Adrenergic alpha-Agonists
-
Antipsychotic Agents
-
Dopamine Agents
-
Botulinum Toxins, Type A